Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Invested Capital: 2023

Historic Return on Invested Capital for Kiniksa Pharmaceuticals International (KNSA) over the last 1 years, with Dec 2023 value amounting to -0.04%.

  • Kiniksa Pharmaceuticals International's Return on Invested Capital rose 11.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 11.00%. This contributed to the annual value of -0.04% for FY2023, which is N/A change from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Return on Invested Capital of -0.04% as of FY2023.
  • Kiniksa Pharmaceuticals International's Return on Invested Capital's 5-year high stood at -0.04% during FY2023, with a 5-year trough of -0.04% in FY2023.
  • Moreover, its 1-year median value for Return on Invested Capital was -0.04% (2023), whereas its average is -0.04%.